SXTPW60 Degrees Pharmaceuticals Inc. Warrant
0.0330USD+10.00%Mkt Cap: —P/E: —8d ago
Industry Peers
Biotechnology$130.23BUSDP/E 32.1
$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
Key Statistics
Company
Market Cap—
Enterprise Value—
Revenue (TTM)—
Gross Profit223.78K $
Net Income (TTM)-7.37M $
Revenue/Share—
Last Price0.0330 USD
Fiscal Year End—
MR Quarter—
Employees—
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B-0.01
EPS (TTM)—
EPS (Forward)—
52W Range
0.022646% of range0.0454
52W High0.0454 USD
52W Low0.0226 USD
Profitability
Gross Margin22.26%
Oper. Margin—
EBITDA Margin—
Profit Margin-732.51%
ROE-212.67%
ROA-137.25%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-6.85M $
CapEx (TTM)218.08K $
FCF Margin—
FCF Yield—
Net Debt—
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.04
Current Ratio—
Quick Ratio—
Book Value/Sh-2.6150 USD
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float—
Insiders—
Institutions—
Technical
SMA 50—
SMA 200—
Beta—
S&P 52W Chg—
Avg Vol (30d)3.90K
Avg Vol (10d)—
Technical Indicators
RSI (14)50.3
MACD-0.0016
MACD Signal-0.0020
MACD Hist.+0.0004
BB Upper0.0427 USD
BB Middle0.0320 USD
BB Lower0.0213 USD
BB Width66.91%
ATR (14)0.0044 USD
Vol Ratio (20d)0.45x